| 0 |
CITROBACTER TEST POSITIVE |
1 |
0.0152 |
| 1 |
CLOSTRIDIUM DIFFICILE SEPSIS |
1 |
0.0089 |
| 2 |
BLOOD CATECHOLAMINES INCREASED |
1 |
0.0080 |
| 3 |
CONGENITAL ANOMALY IN OFFSPRING |
1 |
0.0076 |
| 4 |
LESION EXCISION |
1 |
0.0070 |
| 5 |
FACTITIOUS DISORDER |
1 |
0.0066 |
| 6 |
ADAMS-STOKES SYNDROME |
1 |
0.0065 |
| 7 |
CUTANEOUS CALCIFICATION |
1 |
0.0055 |
| 8 |
PSEUDOALDOSTERONISM |
1 |
0.0051 |
| 9 |
CORTISOL ABNORMAL |
1 |
0.0050 |
| 10 |
GASTROSTOMY TUBE SITE COMPLICATION |
1 |
0.0050 |
| 11 |
HYPERINSULINAEMIC HYPOGLYCAEMIA |
1 |
0.0045 |
| 12 |
FOETAL GROWTH RESTRICTION |
24 |
0.0039 |
| 13 |
VITAMIN B6 DECREASED |
1 |
0.0039 |
| 14 |
HYPOGLYCAEMIA NEONATAL |
6 |
0.0037 |
| 15 |
AGONAL RESPIRATION |
1 |
0.0035 |
| 16 |
HYPEROSMOLAR STATE |
1 |
0.0035 |
| 17 |
PRIMARY ADRENAL INSUFFICIENCY |
1 |
0.0033 |
| 18 |
OESTRADIOL DECREASED |
1 |
0.0031 |
| 19 |
METABOLIC FUNCTION TEST ABNORMAL |
1 |
0.0030 |
| 20 |
ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE |
2 |
0.0027 |
| 21 |
CORTISOL DECREASED |
3 |
0.0026 |
| 22 |
GALLBLADDER PERFORATION |
1 |
0.0026 |
| 23 |
VASCULAR INSUFFICIENCY |
1 |
0.0026 |
| 24 |
ALLERGIC GRANULOMATOUS ANGIITIS |
2 |
0.0024 |
| 25 |
PERIPHERAL SENSORIMOTOR NEUROPATHY |
3 |
0.0024 |
| 26 |
GLUCOCORTICOID DEFICIENCY |
1 |
0.0024 |
| 27 |
BLOOD CREATINE PHOSPHOKINASE ABNORMAL |
1 |
0.0022 |
| 28 |
URTICARIAL VASCULITIS |
1 |
0.0019 |
| 29 |
ADRENAL HAEMORRHAGE |
1 |
0.0018 |
| 30 |
SJOGREN'S SYNDROME |
1 |
0.0017 |
| 31 |
PALATAL DISORDER |
1 |
0.0017 |
| 32 |
ANOXIC ENCEPHALOPATHY |
1 |
0.0016 |
| 33 |
MAGNETIC RESONANCE IMAGING HEAD ABNORMAL |
1 |
0.0015 |
| 34 |
HYPERMAGNESAEMIA |
1 |
0.0015 |
| 35 |
INJECTION SITE EXFOLIATION |
1 |
0.0015 |
| 36 |
RENAL VEIN THROMBOSIS |
1 |
0.0015 |
| 37 |
ANASTOMOTIC LEAK |
1 |
0.0014 |
| 38 |
CUSHING'S SYNDROME |
1 |
0.0014 |
| 39 |
ANTICONVULSANT DRUG LEVEL DECREASED |
2 |
0.0014 |
| 40 |
ESCHAR |
1 |
0.0014 |
| 41 |
CHOLANGITIS ACUTE |
1 |
0.0013 |
| 42 |
DEBRIDEMENT |
1 |
0.0013 |
| 43 |
ADENOMA BENIGN |
1 |
0.0012 |
| 44 |
URINARY TRACT INFECTION ENTEROCOCCAL |
1 |
0.0011 |
| 45 |
INTUSSUSCEPTION |
1 |
0.0010 |
| 46 |
PARTNER STRESS |
1 |
0.0010 |
| 47 |
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS |
2 |
0.0010 |
| 48 |
BLOOD SODIUM ABNORMAL |
1 |
0.0009 |
| 49 |
BLOODY DISCHARGE |
1 |
0.0009 |
| 50 |
STREPTOCOCCAL SEPSIS |
1 |
0.0008 |
| 51 |
ESCHERICHIA TEST POSITIVE |
1 |
0.0008 |
| 52 |
BRONCHIAL HYPERREACTIVITY |
1 |
0.0008 |
| 53 |
ADRENAL INSUFFICIENCY |
10 |
0.0008 |
| 54 |
SUBCUTANEOUS HAEMATOMA |
1 |
0.0008 |
| 55 |
ENDOCRINE DISORDER |
1 |
0.0008 |
| 56 |
OBSTRUCTION GASTRIC |
1 |
0.0008 |
| 57 |
TRANSITIONAL CELL CARCINOMA |
1 |
0.0008 |
| 58 |
PROTEIN TOTAL ABNORMAL |
1 |
0.0008 |
| 59 |
ACROCHORDON |
1 |
0.0008 |
| 60 |
FANCONI SYNDROME |
1 |
0.0007 |
| 61 |
BLOOD ELECTROLYTES DECREASED |
1 |
0.0007 |
| 62 |
BLADDER TRANSITIONAL CELL CARCINOMA |
1 |
0.0007 |
| 63 |
STRIDOR |
2 |
0.0007 |
| 64 |
CONJUNCTIVITIS ALLERGIC |
1 |
0.0007 |
| 65 |
SECONDARY ADRENOCORTICAL INSUFFICIENCY |
1 |
0.0007 |
| 66 |
ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC |
1 |
0.0007 |
| 67 |
NEURITIS |
1 |
0.0006 |
| 68 |
VASOPLEGIA SYNDROME |
1 |
0.0006 |
| 69 |
SEBORRHOEIC DERMATITIS |
1 |
0.0006 |
| 70 |
DERMATITIS EXFOLIATIVE |
3 |
0.0006 |
| 71 |
MYOCARDIAL NECROSIS MARKER INCREASED |
1 |
0.0006 |
| 72 |
HYPOPITUITARISM |
1 |
0.0006 |
| 73 |
ILEAL STENOSIS |
1 |
0.0006 |
| 74 |
TETANY |
1 |
0.0005 |
| 75 |
SUSPECTED PRODUCT QUALITY ISSUE |
1 |
0.0005 |
| 76 |
LOBAR PNEUMONIA |
1 |
0.0005 |
| 77 |
HYPOGLYCAEMIC UNCONSCIOUSNESS |
1 |
0.0005 |
| 78 |
MUSCLE HAEMORRHAGE |
2 |
0.0005 |
| 79 |
HYPOPHYSITIS |
1 |
0.0005 |
| 80 |
CHOLANGITIS SCLEROSING |
1 |
0.0005 |
| 81 |
BODY TEMPERATURE FLUCTUATION |
1 |
0.0005 |
| 82 |
HYPERPHOSPHATAEMIA |
1 |
0.0005 |
| 83 |
PSEUDOMEMBRANOUS COLITIS |
1 |
0.0004 |
| 84 |
METASTATIC MALIGNANT MELANOMA |
1 |
0.0004 |
| 85 |
ISCHAEMIA |
2 |
0.0004 |
| 86 |
ESCHERICHIA BACTERAEMIA |
1 |
0.0004 |
| 87 |
HYPOGLYCAEMIA |
20 |
0.0004 |
| 88 |
CANCER PAIN |
1 |
0.0004 |
| 89 |
PROCTITIS |
1 |
0.0004 |
| 90 |
RENAL TUBULAR DISORDER |
1 |
0.0004 |
| 91 |
OESOPHAGEAL STENOSIS |
1 |
0.0004 |
| 92 |
PHARYNGEAL DISORDER |
1 |
0.0003 |
| 93 |
ESCHERICHIA SEPSIS |
1 |
0.0003 |
| 94 |
ADENOVIRUS INFECTION |
1 |
0.0003 |
| 95 |
HAEMOTHORAX |
1 |
0.0003 |
| 96 |
SKIN WARM |
2 |
0.0003 |
| 97 |
ATYPICAL PNEUMONIA |
1 |
0.0003 |
| 98 |
THYROIDITIS |
1 |
0.0003 |
| 99 |
THROMBOPHLEBITIS SUPERFICIAL |
1 |
0.0003 |
| 100 |
BRAIN DEATH |
1 |
0.0003 |
| 101 |
MULTIPLE-DRUG RESISTANCE |
1 |
0.0003 |
| 102 |
BLOOD CREATININE DECREASED |
1 |
0.0003 |
| 103 |
RESPIRATORY RATE DECREASED |
1 |
0.0003 |
| 104 |
BILE DUCT STONE |
1 |
0.0003 |
| 105 |
HYPERKALAEMIA |
11 |
0.0003 |
| 106 |
SUPRAVENTRICULAR TACHYCARDIA |
3 |
0.0003 |
| 107 |
OCCUPATIONAL EXPOSURE TO PRODUCT |
2 |
0.0003 |
| 108 |
INJECTION SITE INFECTION |
1 |
0.0003 |
| 109 |
PEPTIC ULCER |
1 |
0.0003 |
| 110 |
LEFT VENTRICULAR FAILURE |
1 |
0.0003 |
| 111 |
FOETAL EXPOSURE DURING PREGNANCY |
23 |
0.0003 |
| 112 |
MATERNAL EXPOSURE TIMING UNSPECIFIED |
1 |
0.0003 |
| 113 |
HEPATIC NECROSIS |
1 |
0.0003 |
| 114 |
TROPONIN INCREASED |
2 |
0.0003 |
| 115 |
CONJUNCTIVAL HAEMORRHAGE |
1 |
0.0003 |
| 116 |
EPIGASTRIC DISCOMFORT |
1 |
0.0003 |
| 117 |
CHOLECYSTITIS |
3 |
0.0003 |
| 118 |
INTRACRANIAL ANEURYSM |
1 |
0.0002 |
| 119 |
CYSTITIS HAEMORRHAGIC |
1 |
0.0002 |
| 120 |
EOSINOPHIL COUNT INCREASED |
2 |
0.0002 |
| 121 |
CARDIAC FAILURE CHRONIC |
1 |
0.0002 |
| 122 |
ABDOMINAL ABSCESS |
1 |
0.0002 |
| 123 |
ILEUS PARALYTIC |
1 |
0.0002 |
| 124 |
DRUG LEVEL ABOVE THERAPEUTIC |
1 |
0.0002 |
| 125 |
LOCALISED OEDEMA |
1 |
0.0002 |
| 126 |
NEPHROGENIC ANAEMIA |
1 |
0.0002 |
| 127 |
INTERCEPTED MEDICATION ERROR |
1 |
0.0002 |
| 128 |
HEPATIC STEATOSIS |
4 |
0.0002 |
| 129 |
PULSE ABSENT |
1 |
0.0002 |
| 130 |
SUBCUTANEOUS ABSCESS |
1 |
0.0002 |
| 131 |
ATELECTASIS |
2 |
0.0002 |
| 132 |
ENTEROCOCCAL INFECTION |
1 |
0.0002 |
| 133 |
PHARYNGEAL SWELLING |
2 |
0.0002 |
| 134 |
RENAL TUBULAR NECROSIS |
2 |
0.0002 |
| 135 |
HEPARIN-INDUCED THROMBOCYTOPENIA |
1 |
0.0002 |
| 136 |
HYPERNATRAEMIA |
1 |
0.0002 |
| 137 |
HYPERBILIRUBINAEMIA |
2 |
0.0002 |
| 138 |
FAILURE TO THRIVE |
1 |
0.0002 |
| 139 |
APLASTIC ANAEMIA |
1 |
0.0002 |
| 140 |
SERUM FERRITIN INCREASED |
1 |
0.0002 |
| 141 |
PHARYNGOLARYNGEAL PAIN |
1 |
0.0002 |
| 142 |
HYDROCEPHALUS |
1 |
0.0002 |
| 143 |
ACUTE PULMONARY OEDEMA |
1 |
0.0002 |
| 144 |
ENTEROCOLITIS |
1 |
0.0002 |
| 145 |
STRESS CARDIOMYOPATHY |
1 |
0.0002 |
| 146 |
PRODUCT LABEL CONFUSION |
1 |
0.0002 |
| 147 |
POLYNEUROPATHY |
2 |
0.0002 |
| 148 |
INJECTION SITE VESICLES |
1 |
0.0002 |
| 149 |
PRESYNCOPE |
4 |
0.0002 |
| 150 |
CHOLANGITIS |
1 |
0.0002 |
| 151 |
HYPOCALCAEMIA |
3 |
0.0002 |
| 152 |
ANGINA UNSTABLE |
1 |
0.0002 |
| 153 |
TENDON DISORDER |
1 |
0.0002 |
| 154 |
BLOOD TESTOSTERONE DECREASED |
1 |
0.0001 |
| 155 |
ENCEPHALITIS |
1 |
0.0001 |
| 156 |
HAIR GROWTH ABNORMAL |
1 |
0.0001 |
| 157 |
PULMONARY HYPERTENSION |
3 |
0.0001 |
| 158 |
HYPOXIA |
5 |
0.0001 |
| 159 |
NEUTROPENIC SEPSIS |
1 |
0.0001 |
| 160 |
FLUID OVERLOAD |
2 |
0.0001 |
| 161 |
HYPOPHOSPHATAEMIA |
1 |
0.0001 |
| 162 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0001 |
| 163 |
ARTHROPOD BITE |
1 |
0.0001 |
| 164 |
HAEMORRHAGE INTRACRANIAL |
2 |
0.0001 |
| 165 |
HYDRONEPHROSIS |
1 |
0.0001 |
| 166 |
ACIDOSIS |
1 |
0.0001 |
| 167 |
MATERNAL DRUGS AFFECTING FOETUS |
1 |
0.0001 |
| 168 |
PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 169 |
DEVICE RELATED INFECTION |
2 |
0.0001 |
| 170 |
ATRIOVENTRICULAR BLOCK |
1 |
0.0001 |
| 171 |
CONCUSSION |
1 |
0.0001 |
| 172 |
APNOEA |
1 |
0.0001 |
| 173 |
BLOOD ALBUMIN DECREASED |
1 |
0.0001 |
| 174 |
RENAL CYST |
1 |
0.0001 |
| 175 |
SUBSTANCE ABUSE |
1 |
0.0001 |
| 176 |
POLYURIA |
1 |
0.0001 |
| 177 |
ABNORMAL FAECES |
1 |
0.0001 |
| 178 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
3 |
0.0001 |
| 179 |
VITAMIN D DECREASED |
1 |
0.0001 |
| 180 |
DRUG RESISTANCE |
3 |
0.0001 |
| 181 |
PRODUCT CONTAINER ISSUE |
1 |
0.0001 |
| 182 |
MULTI-ORGAN FAILURE |
2 |
0.0001 |
| 183 |
PYELONEPHRITIS |
1 |
0.0001 |
| 184 |
NEUROTOXICITY |
2 |
0.0001 |
| 185 |
SPINAL OSTEOARTHRITIS |
1 |
0.0001 |
| 186 |
TUMOUR LYSIS SYNDROME |
1 |
0.0001 |
| 187 |
PRODUCT COMMUNICATION ISSUE |
1 |
0.0001 |
| 188 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
2 |
0.0001 |
| 189 |
RESPIRATORY RATE INCREASED |
1 |
0.0001 |
| 190 |
WRONG DRUG ADMINISTERED |
1 |
0.0001 |
| 191 |
RESPIRATORY DISTRESS |
3 |
0.0001 |
| 192 |
INCREASED TENDENCY TO BRUISE |
1 |
0.0001 |
| 193 |
NEPHROPATHY |
1 |
0.0001 |
| 194 |
SPUTUM DISCOLOURED |
1 |
0.0001 |
| 195 |
HYPERCHOLESTEROLAEMIA |
1 |
0.0001 |
| 196 |
PARKINSONISM |
1 |
0.0001 |
| 197 |
EMPHYSEMA |
1 |
0.0001 |
| 198 |
HYPOTHERMIA |
1 |
0.0001 |
| 199 |
SEPSIS |
11 |
0.0001 |
| 200 |
SUBARACHNOID HAEMORRHAGE |
1 |
0.0001 |
| 201 |
NEUTROPHIL COUNT INCREASED |
1 |
0.0001 |
| 202 |
FULL BLOOD COUNT ABNORMAL |
1 |
0.0001 |
| 203 |
CLOSTRIDIUM DIFFICILE COLITIS |
1 |
0.0001 |
| 204 |
HYPOTENSION |
18 |
0.0001 |
| 205 |
PANCYTOPENIA |
5 |
0.0001 |
| 206 |
MALNUTRITION |
1 |
0.0001 |
| 207 |
PULMONARY OEDEMA |
4 |
0.0001 |
| 208 |
HYPONATRAEMIA |
5 |
0.0001 |
| 209 |
IMPAIRED DRIVING ABILITY |
1 |
0.0001 |
| 210 |
SHOCK |
2 |
0.0001 |
| 211 |
PERICARDIAL EFFUSION |
2 |
0.0001 |
| 212 |
VASCULITIS |
1 |
0.0001 |
| 213 |
SPINAL PAIN |
1 |
0.0001 |
| 214 |
HYPERLIPIDAEMIA |
1 |
0.0001 |
| 215 |
ENCEPHALOPATHY |
2 |
0.0001 |
| 216 |
ILEUS |
1 |
0.0001 |
| 217 |
SYNCOPE |
8 |
0.0001 |
| 218 |
BRAIN OEDEMA |
1 |
0.0001 |
| 219 |
ANAPHYLACTIC SHOCK |
2 |
0.0001 |
| 220 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 221 |
PULMONARY CONGESTION |
1 |
0.0001 |
| 222 |
SINUS CONGESTION |
1 |
0.0001 |
| 223 |
TACHYPNOEA |
1 |
0.0001 |
| 224 |
PALLOR |
2 |
0.0001 |
| 225 |
GINGIVAL BLEEDING |
1 |
0.0001 |
| 226 |
CENTRAL NERVOUS SYSTEM LESION |
1 |
0.0001 |
| 227 |
MENTAL STATUS CHANGES |
2 |
0.0001 |
| 228 |
HYPOMAGNESAEMIA |
1 |
0.0001 |
| 229 |
HUNGER |
1 |
0.0001 |
| 230 |
BLOOD TEST ABNORMAL |
1 |
0.0001 |
| 231 |
DISSEMINATED INTRAVASCULAR COAGULATION |
1 |
0.0001 |
| 232 |
RENAL FAILURE ACUTE |
3 |
0.0001 |
| 233 |
SINUS TACHYCARDIA |
1 |
0.0001 |
| 234 |
PARALYSIS |
1 |
0.0001 |
| 235 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
2 |
0.0001 |
| 236 |
HYPERTHYROIDISM |
1 |
0.0001 |
| 237 |
SEPTIC SHOCK |
3 |
0.0001 |
| 238 |
LIVER FUNCTION TEST ABNORMAL |
2 |
0.0001 |
| 239 |
MATERNAL EXPOSURE DURING PREGNANCY |
6 |
0.0001 |
| 240 |
PULMONARY MASS |
1 |
0.0001 |
| 241 |
ECONOMIC PROBLEM |
1 |
0.0001 |
| 242 |
PHARYNGEAL OEDEMA |
1 |
0.0001 |
| 243 |
THYROID DISORDER |
1 |
0.0001 |
| 244 |
BASAL CELL CARCINOMA |
1 |
0.0001 |
| 245 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
1 |
0.0001 |
| 246 |
ULCER |
1 |
0.0001 |
| 247 |
CYSTITIS |
2 |
0.0001 |
| 248 |
SCIATICA |
1 |
0.0001 |
| 249 |
HYPOTHYROIDISM |
2 |
0.0001 |
| 250 |
MUSCLE TIGHTNESS |
1 |
0.0001 |
| 251 |
BLOOD POTASSIUM INCREASED |
1 |
0.0001 |
| 252 |
BACK DISORDER |
1 |
0.0001 |
| 253 |
BLOOD CREATININE INCREASED |
4 |
0.0001 |
| 254 |
STAPHYLOCOCCAL INFECTION |
2 |
0.0001 |
| 255 |
FUNGAL INFECTION |
2 |
0.0001 |
| 256 |
RENAL IMPAIRMENT |
5 |
0.0001 |
| 257 |
CIRCULATORY COLLAPSE |
1 |
0.0001 |
| 258 |
PARANOIA |
1 |
0.0001 |
| 259 |
DELIRIUM |
2 |
0.0001 |
| 260 |
LOCAL SWELLING |
1 |
0.0001 |
| 261 |
BLOOD TRIGLYCERIDES INCREASED |
1 |
0.0001 |
| 262 |
ASPARTATE AMINOTRANSFERASE INCREASED |
3 |
0.0001 |
| 263 |
GALLBLADDER DISORDER |
1 |
0.0001 |
| 264 |
BONE DISORDER |
1 |
0.0001 |
| 265 |
END STAGE RENAL DISEASE |
1 |
0.0001 |
| 266 |
CONJUNCTIVITIS |
1 |
0.0001 |
| 267 |
THROMBOCYTOPENIA |
6 |
0.0001 |
| 268 |
OXYGEN SATURATION DECREASED |
3 |
0.0001 |
| 269 |
MUSCULOSKELETAL DISORDER |
1 |
0.0001 |
| 270 |
PULMONARY FIBROSIS |
1 |
0.0001 |
| 271 |
CHOLESTASIS |
1 |
0.0001 |
| 272 |
POST PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 273 |
ACUTE RESPIRATORY FAILURE |
1 |
0.0001 |
| 274 |
DYSTONIA |
1 |
0.0001 |
| 275 |
MENORRHAGIA |
1 |
0.0001 |
| 276 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 277 |
CYTOKINE RELEASE SYNDROME |
1 |
0.0000 |
| 278 |
CARDIAC FAILURE |
4 |
0.0000 |
| 279 |
PRODUCT ADMINISTRATION ERROR |
1 |
0.0000 |
| 280 |
DYSKINESIA |
2 |
0.0000 |
| 281 |
NEUTROPHIL COUNT DECREASED |
2 |
0.0000 |
| 282 |
ALANINE AMINOTRANSFERASE INCREASED |
3 |
0.0000 |
| 283 |
PRODUCT PREPARATION ERROR |
1 |
0.0000 |
| 284 |
RIB FRACTURE |
1 |
0.0000 |
| 285 |
DERMATITIS |
1 |
0.0000 |
| 286 |
POOR QUALITY SLEEP |
1 |
0.0000 |
| 287 |
RHINORRHOEA |
3 |
0.0000 |
| 288 |
FAECES DISCOLOURED |
1 |
0.0000 |
| 289 |
FEBRILE NEUTROPENIA |
3 |
0.0000 |
| 290 |
TACHYCARDIA |
4 |
0.0000 |
| 291 |
STEVENS-JOHNSON SYNDROME |
1 |
0.0000 |
| 292 |
TRANSAMINASES INCREASED |
1 |
0.0000 |
| 293 |
RASH PAPULAR |
1 |
0.0000 |
| 294 |
PRODUCT AVAILABILITY ISSUE |
1 |
0.0000 |
| 295 |
BLOOD PRESSURE FLUCTUATION |
1 |
0.0000 |
| 296 |
RESPIRATORY FAILURE |
3 |
0.0000 |
| 297 |
ATRIAL FIBRILLATION |
4 |
0.0000 |
| 298 |
PNEUMONIA |
13 |
0.0000 |
| 299 |
LEUKOPENIA |
2 |
0.0000 |
| 300 |
HYPOPHAGIA |
1 |
0.0000 |
| 301 |
CHEST DISCOMFORT |
4 |
0.0000 |
| 302 |
UNRESPONSIVE TO STIMULI |
1 |
0.0000 |
| 303 |
PHARMACEUTICAL PRODUCT COMPLAINT |
1 |
0.0000 |
| 304 |
JOINT STIFFNESS |
1 |
0.0000 |
| 305 |
ANHEDONIA |
1 |
0.0000 |
| 306 |
GASTRITIS |
1 |
0.0000 |
| 307 |
RENAL FAILURE |
5 |
0.0000 |
| 308 |
EAR INFECTION |
1 |
0.0000 |
| 309 |
MENSTRUATION IRREGULAR |
1 |
0.0000 |
| 310 |
DISTURBANCE IN ATTENTION |
2 |
0.0000 |
| 311 |
PNEUMONITIS |
1 |
0.0000 |
| 312 |
TREMOR |
6 |
0.0000 |
| 313 |
MEDICATION ERROR |
2 |
0.0000 |
| 314 |
FEELING COLD |
1 |
0.0000 |
| 315 |
WOUND |
1 |
0.0000 |
| 316 |
BALANCE DISORDER |
3 |
0.0000 |
| 317 |
PALPITATIONS |
4 |
0.0000 |
| 318 |
CHILLS |
4 |
0.0000 |
| 319 |
ACUTE MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 320 |
WHEEZING |
2 |
0.0000 |
| 321 |
HYPERTENSION |
7 |
0.0000 |
| 322 |
PLEURAL EFFUSION |
2 |
0.0000 |
| 323 |
EPILEPSY |
1 |
0.0000 |
| 324 |
DRUG-INDUCED LIVER INJURY |
1 |
0.0000 |
| 325 |
METABOLIC ACIDOSIS |
1 |
0.0000 |
| 326 |
DEEP VEIN THROMBOSIS |
2 |
0.0000 |
| 327 |
CHOLELITHIASIS |
1 |
0.0000 |
| 328 |
IMPAIRED HEALING |
1 |
0.0000 |
| 329 |
HEART RATE INCREASED |
3 |
0.0000 |
| 330 |
INFUSION RELATED REACTION |
2 |
0.0000 |
| 331 |
BLOOD PRESSURE DECREASED |
2 |
0.0000 |
| 332 |
EXPIRED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 333 |
DEHYDRATION |
4 |
0.0000 |
| 334 |
TRANSIENT ISCHAEMIC ATTACK |
1 |
0.0000 |
| 335 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
1 |
0.0000 |
| 336 |
PANIC ATTACK |
1 |
0.0000 |
| 337 |
DYSURIA |
1 |
0.0000 |
| 338 |
HYPOAESTHESIA |
4 |
0.0000 |
| 339 |
PRODUCT USE ISSUE |
5 |
0.0000 |
| 340 |
DYSARTHRIA |
1 |
0.0000 |
| 341 |
HOT FLUSH |
2 |
0.0000 |
| 342 |
INTESTINAL OBSTRUCTION |
1 |
0.0000 |
| 343 |
CHRONIC KIDNEY DISEASE |
2 |
0.0000 |
| 344 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 345 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
1 |
0.0000 |
| 346 |
ABORTION SPONTANEOUS |
1 |
0.0000 |
| 347 |
CARDIAC FAILURE CONGESTIVE |
2 |
0.0000 |
| 348 |
PSORIATIC ARTHROPATHY |
1 |
0.0000 |
| 349 |
OEDEMA PERIPHERAL |
3 |
0.0000 |
| 350 |
LUNG NEOPLASM MALIGNANT |
1 |
0.0000 |
| 351 |
CARDIAC ARREST |
2 |
0.0000 |
| 352 |
RHABDOMYOLYSIS |
1 |
0.0000 |
| 353 |
CARDIO-RESPIRATORY ARREST |
1 |
0.0000 |
| 354 |
SKIN EXFOLIATION |
2 |
0.0000 |
| 355 |
OSTEOARTHRITIS |
1 |
0.0000 |
| 356 |
URINARY TRACT INFECTION |
4 |
0.0000 |
| 357 |
DYSPNOEA |
13 |
0.0000 |
| 358 |
RASH |
10 |
0.0000 |
| 359 |
PRODUCT STORAGE ERROR |
2 |
0.0000 |
| 360 |
NEUTROPENIA |
3 |
0.0000 |
| 361 |
NEPHROLITHIASIS |
1 |
0.0000 |
| 362 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 363 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 364 |
CHEST PAIN |
4 |
0.0000 |
| 365 |
HYPERSENSITIVITY |
4 |
0.0000 |
| 366 |
BLOOD CHOLESTEROL INCREASED |
1 |
0.0000 |
| 367 |
ANXIETY |
6 |
0.0000 |
| 368 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 369 |
BLOOD GLUCOSE DECREASED |
1 |
0.0000 |
| 370 |
LUNG DISORDER |
1 |
0.0000 |
| 371 |
ACUTE KIDNEY INJURY |
3 |
0.0000 |
| 372 |
ILLNESS |
2 |
0.0000 |
| 373 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
1 |
0.0000 |
| 374 |
ABDOMINAL DISTENSION |
2 |
0.0000 |
| 375 |
SPEECH DISORDER |
1 |
0.0000 |
| 376 |
PANCREATITIS |
1 |
0.0000 |
| 377 |
DRUG INTERACTION |
3 |
0.0000 |
| 378 |
BRADYCARDIA |
1 |
0.0000 |
| 379 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 380 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 381 |
FALL |
6 |
0.0000 |
| 382 |
URTICARIA |
3 |
0.0000 |
| 383 |
LETHARGY |
1 |
0.0000 |
| 384 |
GENERAL PHYSICAL HEALTH DETERIORATION |
2 |
0.0000 |
| 385 |
ABDOMINAL PAIN |
4 |
0.0000 |
| 386 |
COVID-19 |
3 |
0.0000 |
| 387 |
DYSPHONIA |
1 |
0.0000 |
| 388 |
BONE PAIN |
1 |
0.0000 |
| 389 |
NASAL CONGESTION |
1 |
0.0000 |
| 390 |
PAIN IN EXTREMITY |
5 |
0.0000 |
| 391 |
STOMATITIS |
1 |
0.0000 |
| 392 |
VERTIGO |
1 |
0.0000 |
| 393 |
FEELING HOT |
1 |
0.0000 |
| 394 |
EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 395 |
DIZZINESS |
8 |
0.0000 |
| 396 |
ANAEMIA |
3 |
0.0000 |
| 397 |
GAIT DISTURBANCE |
3 |
0.0000 |
| 398 |
NAUSEA |
12 |
0.0000 |
| 399 |
SOMNOLENCE |
3 |
0.0000 |
| 400 |
MULTIPLE SCLEROSIS RELAPSE |
1 |
0.0000 |
| 401 |
VISION BLURRED |
2 |
0.0000 |
| 402 |
MEMORY IMPAIRMENT |
2 |
0.0000 |
| 403 |
COUGH |
4 |
0.0000 |
| 404 |
INJURY |
1 |
0.0000 |
| 405 |
SLEEP DISORDER |
1 |
0.0000 |
| 406 |
CONSTIPATION |
3 |
0.0000 |
| 407 |
BRONCHITIS |
1 |
0.0000 |
| 408 |
WEIGHT INCREASED |
3 |
0.0000 |
| 409 |
EPISTAXIS |
1 |
0.0000 |
| 410 |
ASTHENIA |
5 |
0.0000 |
| 411 |
DIABETES MELLITUS |
1 |
0.0000 |
| 412 |
BLOOD PRESSURE INCREASED |
2 |
0.0000 |
| 413 |
INJECTION SITE SWELLING |
1 |
0.0000 |
| 414 |
PERIPHERAL SWELLING |
2 |
0.0000 |
| 415 |
BACK PAIN |
3 |
0.0000 |
| 416 |
ARTHRITIS |
1 |
0.0000 |
| 417 |
INJECTION SITE BRUISING |
1 |
0.0000 |
| 418 |
FEELING ABNORMAL |
3 |
0.0000 |
| 419 |
THROMBOSIS |
1 |
0.0000 |
| 420 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 421 |
PRODUCT USE IN UNAPPROVED INDICATION |
3 |
0.0000 |
| 422 |
TREATMENT FAILURE |
1 |
0.0000 |
| 423 |
MYOCARDIAL INFARCTION |
2 |
0.0000 |
| 424 |
INTENTIONAL PRODUCT MISUSE |
1 |
0.0000 |
| 425 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 426 |
HEADACHE |
7 |
0.0000 |
| 427 |
NO ADVERSE EVENT |
2 |
0.0000 |
| 428 |
NASOPHARYNGITIS |
2 |
0.0000 |
| 429 |
WEIGHT DECREASED |
3 |
0.0000 |
| 430 |
SWELLING |
1 |
0.0000 |
| 431 |
VOMITING |
5 |
0.0000 |
| 432 |
DYSPHAGIA |
1 |
0.0000 |
| 433 |
PULMONARY EMBOLISM |
1 |
0.0000 |
| 434 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 435 |
CONTUSION |
1 |
0.0000 |
| 436 |
ALOPECIA |
2 |
0.0000 |
| 437 |
FLUSHING |
1 |
0.0000 |
| 438 |
MALIGNANT NEOPLASM PROGRESSION |
1 |
0.0000 |
| 439 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 440 |
ARTHRALGIA |
4 |
0.0000 |
| 441 |
PLATELET COUNT DECREASED |
1 |
0.0000 |
| 442 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 443 |
OFF LABEL USE |
8 |
0.0000 |
| 444 |
INFLUENZA |
1 |
0.0000 |
| 445 |
SEIZURE |
1 |
0.0000 |
| 446 |
DECREASED APPETITE |
2 |
0.0000 |
| 447 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 448 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 449 |
INJECTION SITE ERYTHEMA |
1 |
0.0000 |
| 450 |
DRY SKIN |
1 |
0.0000 |
| 451 |
CONDITION AGGRAVATED |
2 |
0.0000 |
| 452 |
INJECTION SITE PAIN |
2 |
0.0000 |
| 453 |
PAIN |
4 |
0.0000 |
| 454 |
FATIGUE |
5 |
0.0000 |
| 455 |
PARAESTHESIA |
1 |
0.0000 |
| 456 |
DIARRHOEA |
4 |
0.0000 |
| 457 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 458 |
ABDOMINAL DISCOMFORT |
1 |
0.0000 |
| 459 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 460 |
PYREXIA |
2 |
0.0000 |
| 461 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 462 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 463 |
PRURITUS |
2 |
0.0000 |
| 464 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 465 |
ERYTHEMA |
1 |
0.0000 |
| 466 |
MALAISE |
2 |
0.0000 |
| 467 |
DRUG INEFFECTIVE |
6 |
0.0000 |
| 468 |
DEPRESSION |
1 |
0.0000 |
| 469 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 470 |
INSOMNIA |
1 |
0.0000 |
| 471 |
DEATH |
3 |
0.0000 |